Evidence map›Paper›PMID 39117418›Full record

Observational studyBMJ open2024

Analyses of the association between

Sho Yamasaki, Masayuki Murata, Azusa Ohta, Yuji Matsumoto, Hiroaki Ikezaki, Norihiro Furusyo

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Diagnosis and treatment ofFuture microbiology · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sho YamasakiDepartment of Environmental Medicine and Infectious Diseases, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.ORCID 0000-0002-2953-7659
Masayuki MurataDepartment of General Internal Medicine, Kyushu University Hospital, Fukuoka, Japan masayuki.murata.097@m.kyushu-u.ac.jp.
Azusa OhtaDepartment of Environmental Medicine and Infectious Diseases, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Yuji MatsumotoDepartment of Environmental Medicine and Infectious Diseases, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Hiroaki IkezakiDepartment of Comprehensive General Internal Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.ORCID 0000-0002-6677-6341
Norihiro FurusyoDepartment of General Internal Medicine, Kyushu University Hospital, Fukuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess the utility of

designA retrospective observational cohort study. SETTING AND

participantsFrom 2004 to 2016, medical check-ups were performed in different regions of Japan. In total, 324 subjects infected with

resultsThe

conclusionsOur data indicate that the

Indexed as

Antibodies, BacterialHelicobacter InfectionsHelicobacter pyloriPepsinogen AAdultAgedAnti-Bacterial AgentsAntigens, BacterialBacterial ProteinsFemaleHumansJapanMaleMiddle AgedPepsinogen CRetrospective StudiesAnti-Bacterial AgentsAntibodies, BacterialAntigens, BacterialBacterial ProteinscagA protein, Helicobacter pyloriPepsinogen APepsinogen CVacA protein, Helicobacter pyloriDiagnostic microbiologyEpidemiologyGastroenterologyGastrointestinal infections

Identifiers

PMID39117418
PMCPMC11404197

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.